The in vitro diagnostics (IVD) market in Asia is experiencing significant growth and transformation, driven by a combination of technological advancements, increasing healthcare awareness, and a growing aging population. As the demand for accurate and timely disease diagnosis rises, the IVD sector is playing a crucial role in shaping the healthcare landscape across the region. Several trends are shaping the IVD market in Asia. Firstly, rapid technological innovation in areas such as molecular diagnostics, point-of-care testing, and automation is enhancing the accuracy, speed, and accessibility of diagnostic tests.
This is particularly important in regions with limited healthcare infrastructure, enabling faster disease detection and treatment. Secondly, the increasing prevalence of chronic diseases, infectious diseases, and lifestyle-related health issues is propelling the... >>More
Zoya Brar, Founder, CORE Diagnostics
John W Mitchell, President & CEO, IPC
Irene Kwan, Chief Executive Officer, TMC Fertility
Shobhit Sethi, Associate Director/QA Practice Head, InfoBeans...
John Kallelil, Founder & CEO, XED